Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Samuraciclib by Carrick Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval
Samuraciclib is under clinical development by Carrick Therapeutics and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...
Data Insights
Samuraciclib by Carrick Therapeutics for Ovarian Cancer: Likelihood of Approval
Samuraciclib is under clinical development by Carrick Therapeutics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...